Chunnuan Wu

811 total citations
29 papers, 709 citations indexed

About

Chunnuan Wu is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Chunnuan Wu has authored 29 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmaceutical Science, 9 papers in Biomaterials and 7 papers in Molecular Biology. Recurrent topics in Chunnuan Wu's work include Drug Solubulity and Delivery Systems (11 papers), Nanoparticle-Based Drug Delivery (9 papers) and Advanced Drug Delivery Systems (6 papers). Chunnuan Wu is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Nanoparticle-Based Drug Delivery (9 papers) and Advanced Drug Delivery Systems (6 papers). Chunnuan Wu collaborates with scholars based in China, United States and Taiwan. Chunnuan Wu's co-authors include Jin Sun, Zhonggui He, Xiaoyu Ai, He Lian, Yuqian Du, Zhonggui He, Cong Luo, Qiang Fu, Xiaopeng Han and Lin Li and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and RSC Advances.

In The Last Decade

Chunnuan Wu

29 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunnuan Wu China 14 281 276 224 143 110 29 709
Rohan Ghadi India 15 337 1.2× 258 0.9× 240 1.1× 141 1.0× 131 1.2× 27 801
Abhay T. Sangamwar India 12 301 1.1× 346 1.3× 225 1.0× 121 0.8× 101 0.9× 15 758
Xiaohui Pu China 19 272 1.0× 209 0.8× 329 1.5× 169 1.2× 116 1.1× 42 844
Sunitha Sampathi India 16 193 0.7× 315 1.1× 190 0.8× 109 0.8× 64 0.6× 37 734
Ravinder Verma India 14 209 0.7× 212 0.8× 207 0.9× 166 1.2× 64 0.6× 61 835
Kwan Hyung Cho South Korea 18 150 0.5× 377 1.4× 169 0.8× 90 0.6× 61 0.6× 64 828
Zongning Yin China 20 325 1.2× 525 1.9× 390 1.7× 177 1.2× 91 0.8× 59 1.2k
Subramanian Natesan India 19 247 0.9× 421 1.5× 302 1.3× 181 1.3× 61 0.6× 52 1.1k
Jae Geun Song South Korea 14 253 0.9× 291 1.1× 301 1.3× 141 1.0× 51 0.5× 26 782

Countries citing papers authored by Chunnuan Wu

Since Specialization
Citations

This map shows the geographic impact of Chunnuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunnuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunnuan Wu more than expected).

Fields of papers citing papers by Chunnuan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunnuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunnuan Wu. The network helps show where Chunnuan Wu may publish in the future.

Co-authorship network of co-authors of Chunnuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunnuan Wu. A scholar is included among the top collaborators of Chunnuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunnuan Wu. Chunnuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Boyu, Ling Liu, Xiaofeng Wang, et al.. (2025). Multi-omics analysis reveals ACOT1 as the key target of piperine in Piper Longum-mediated gastric cancer treatment. Chinese Medicine. 20(1). 133–133. 1 indexed citations
4.
Wu, Chunnuan, et al.. (2022). Prediction for optimal dosage of pazopanib under various clinical situations using physiologically based pharmacokinetic modeling. Frontiers in Pharmacology. 13. 963311–963311. 7 indexed citations
5.
Zhao, Jun, Boyu Pan, Xinglu Zhou, et al.. (2022). Polygonum cuspidatum inhibits the growth of osteosarcoma cells via impeding Akt/ERK/EGFR signaling pathways. Bioengineered. 13(2). 2992–3006. 11 indexed citations
6.
Pan, Boyu, Yun Wang, Chunnuan Wu, et al.. (2021). A Mechanism of Action Study on Danggui Sini Decoction to Discover Its Therapeutic Effect on Gastric Cancer. Frontiers in Pharmacology. 11. 592903–592903. 17 indexed citations
7.
Chen, Yuhong, et al.. (2021). Network pharmacology-guided mechanism study uncovers inhibitory effect of Mahuang Decoction on lung cancer growth by impeding Akt/ERK signaling pathways.. American Journal of Translational Research. 13(4). 2094–2110. 4 indexed citations
8.
Li, Xiaoting, Yu Zhang, Chunnuan Wu, et al.. (2019). Justification of Biowaiver and Dissolution Rate Specifications for Piroxicam Immediate Release Products Based on Physiologically Based Pharmacokinetic Modeling: An In-Depth Analysis. Molecular Pharmaceutics. 16(9). 3780–3790. 25 indexed citations
9.
10.
Wu, Chunnuan, Yan Liu, Zhonggui He, & Jin Sun. (2016). Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives. Current Drug Delivery. 13(7). 1004–1020. 6 indexed citations
11.
Sun, Mengchi, Chunnuan Wu, Qiang Fu, et al.. (2016). Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions. International Journal of Pharmaceutics. 503(1-2). 238–246. 53 indexed citations
12.
Tao, Wenhui, Dong Zhang, Chunnuan Wu, et al.. (2016). The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo. Asian Journal of Pharmaceutical Sciences. 12(3). 285–291. 48 indexed citations
13.
Wu, Chunnuan, et al.. (2016). Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs. Asian Journal of Pharmaceutical Sciences. 12(1). 98–104. 12 indexed citations
14.
Fu, Qiang, Chunnuan Wu, Zhibin Guo, et al.. (2015). Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: A case study of lovastatin. Colloids and Surfaces B Biointerfaces. 128. 410–418. 55 indexed citations
15.
Zhang, Qi, Jin Sun, Jinling Zhang, et al.. (2015). A rapid and sensitive LC‐MS/MS method for evaluation of the absolute oral bioavailability of a novel c‐Met tyrosine kinase inhibitor QBH‐196 in rats. Biomedical Chromatography. 29(11). 1650–1656. 5 indexed citations
18.
Wu, Chunnuan, Le Sun, Jin Sun, et al.. (2013). Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology. International Journal of Pharmaceutics. 453(2). 300–306. 16 indexed citations
19.
Lian, He, Tianhong Zhang, Jin Sun, et al.. (2013). Enhanced Oral Delivery of Paclitaxel Using Acetylcysteine Functionalized Chitosan-Vitamin E Succinate Nanomicelles Based on a Mucus Bioadhesion and Penetration Mechanism. Molecular Pharmaceutics. 10(9). 3447–3458. 73 indexed citations
20.
Sun, Le, Xiaohong Liu, Rongwu Xiang, et al.. (2013). Structure‐based prediction of human intestinal membrane permeability for rapidin silicoBCS classification. Biopharmaceutics & Drug Disposition. 34(6). 321–335. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026